Gonzalo et al. reported that epidermal growth factor (EGF) could stimulate G0/G1-S transition via p38 MAPK to overcome the growth restriction of androgen deprivation in prostate cancer cells (Rodriguez-Berriguete et al., 2016). Here, EGF is linked to prostate cancer.